Jane Street’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-70,814
| Closed | -$3.33M | – | 11741 |
|
|
2025
Q2 | $3.33M | Sell |
70,814
-94,073
| -57% | -$4.19M | ﹤0.01% | 3593 |
|
|
2025
Q1 | $7.28M | Buy |
164,887
+117,876
| +251% | +$5.43M | ﹤0.01% | 2391 |
|
|
2024
Q4 | $1.7M | Sell |
47,011
-34,641
| -42% | -$1.21M | ﹤0.01% | 4414 |
|
|
2024
Q3 | $2.62M | Sell |
81,652
-141,125
| -63% | -$5.27M | ﹤0.01% | 3957 |
|
|
2024
Q2 | $8.39M | Sell |
222,777
-358,161
| -62% | -$15.1M | ﹤0.01% | 2243 |
|
|
2024
Q1 | $28.6M | Buy |
580,938
+459,342
| +378% | +$21.2M | 0.01% | 948 |
|
|
2023
Q4 | $4.44M | Buy |
121,596
+83,392
| +218% | +$2.18M | ﹤0.01% | 3024 |
|
|
2023
Q3 | $883K | Sell |
38,204
-204,558
| -84% | -$5.59M | ﹤0.01% | 5375 |
|
|
2023
Q2 | $6.37M | Buy |
242,762
+188,314
| +346% | +$4.95M | ﹤0.01% | 2426 |
|
|
2023
Q1 | $1.4M | Buy |
+54,448
| New | +$1.59M | ﹤0.01% | 4413 |
|
|
2022
Q3 | – | Sell |
-22,196
| Closed | -$636K | – | 10440 |
|
|
2022
Q2 | $547K | Sell |
22,196
-10,273
| -32% | -$376K | ﹤0.01% | 6580 |
|
|
2022
Q1 | $1.83M | Buy |
32,469
+14,495
| +81% | +$829K | ﹤0.01% | 4917 |
|
|
2021
Q4 | $1.11M | Sell |
17,974
-2,892
| -14% | -$191K | ﹤0.01% | 5669 |
|
|
2021
Q3 | $1.32M | Buy |
+20,866
| New | +$1.61M | ﹤0.01% | 5336 |
|
|
2020
Q4 | – | Sell |
-28,573
| Closed | -$1.36M | – | 8100 |
|
|
2020
Q3 | $1.36M | Buy |
28,573
+19,878
| +229% | +$847K | ﹤0.01% | 3602 |
|
|
2020
Q2 | $365K | Buy |
+8,695
| New | +$309K | ﹤0.01% | 5544 |
|
|
2019
Q4 | – | Sell |
-14,142
| Closed | -$307K | – | 5723 |
|
|
2019
Q3 | $307K | Buy |
+14,142
| New | +$334K | ﹤0.01% | 4157 |
|
Other funds holding SWTX
Jane Street's SWTX Position: Q3 2025 in Review
Jane Street sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 70,814 shares — an estimated $3.33M sold.
Jane Street first reported a position in SWTX in Q3 2019 and held it in 17 quarters. The position peaked at $28.6M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Jane Street reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 70,814 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.33M.
- Jane Street first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 17 quarters.
- Jane Street's SpringWorks Therapeutics position peaked at $28.6M in Q1 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.